The primary endpoint was the mean difference SD ( 95 % CI ) in TG levels ( baseline from the end of treatment ) , which were -3 125.6 ( -59.1 , 58.5 ) , 41.6 86.3 ( 1.2 , 82 ) , and 57.1 94.9 ( 12.7 , 101.6 ) in the APE-L , APE-H , and gemfibrozil groups , respectively .